Sponsor
University of California, San Diego
Status
Enrolling by invitation
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT06931860
The objective of this study is to measure the comparative effectiveness of mailed outreach of two stool based tests, multi-target stool DNA (Cologuard) and the fecal immunochemical test (FIT) in screening eligible adults ages 45-49 receiving care at the University of California San Diego Health system.
Intervention
Cologuard, Fecal Immunochemical Test
Condition
Colorectal Cancer Screening, Fecal Immunochemical Test, Multi-target Stool DNA, Colorectal Cancer (CRC)
Investigators
Joshua Demb, PhD, MPH